# Vitamin D Increases Serum Levels of the Soluble Receptor for Advanced Glycation End Products in Women With PCOS

> **NCT03644212** · PHASE4 · COMPLETED · sponsor: **Maimonides Medical Center** · enrollment: 79 (actual)

## Conditions studied

- Polycystic Ovary Syndrome
- Vitamin D Deficiency

## Interventions

- **DRUG:** Vitamin D3

## Key facts

- **NCT ID:** NCT03644212
- **Lead sponsor:** Maimonides Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2013-09
- **Final completion:** 2013-10
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2020-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03644212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03644212, "Vitamin D Increases Serum Levels of the Soluble Receptor for Advanced Glycation End Products in Women With PCOS". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03644212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*